Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3‐mediated E2F1 activation
Hang Song, Yan Liu, Xinquan Li, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 7
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 120
Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression
Lirong Peng, Banglun Pan, Xiaoxia Zhang, et al.
Cell Biology and Toxicology (2022) Vol. 38, Iss. 6, pp. 1159-1173
Closed Access | Times Cited: 83
Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 218-218
Open Access | Times Cited: 72
Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205
Yan Zeng, Wei Du, Zhongying Huang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 47
Current insight into the regulation of PD-L1 in cancer
Zhuandi Liu, Xibao Yu, Ling Xu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 61
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4286-4286
Open Access | Times Cited: 27
The role of LncRNAs in tumor immunotherapy
Xuan Pan, Chenchen Li, Jifeng Feng
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation
Xianjie Jiang, Mingjing Peng, Qiang Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming
Shizhen Li, Mingjing Peng, Shiming Tan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy
Lokesh Kadian, Deepika Verma, Neelam Lohani, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3229-3254
Closed Access | Times Cited: 8
MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4
Chong Bao, Jing Zhang, Shu‐Yue Xian, et al.
Free Radical Research (2021) Vol. 55, Iss. 7, pp. 743-754
Closed Access | Times Cited: 49
m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer
Yanyun Wang, Man Li, Lin Zhang, et al.
Molecular Therapy — Oncolytics (2021) Vol. 21, pp. 367-376
Open Access | Times Cited: 45
circ_0086296 induced atherosclerotic lesions via the IFIT1/STAT1 feedback loop by sponging miR-576-3p
Min Zhang, Yiqian Zhu, Jie Zhu, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 31
Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition
Shengwei Tao, Shuhang Liang, Taofei Zeng, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 17
CAFs-secreted exosomal cricN4BP2L2 promoted colorectal cancer stemness and chemoresistance by interacting with EIF4A3
Zhan Qu, Keda Yang, Baihua Luo, et al.
Experimental Cell Research (2022) Vol. 418, Iss. 2, pp. 113266-113266
Closed Access | Times Cited: 26
N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation
Rongjun Xie, Longfei Liu, Xianzhou Lu, et al.
Gastric Cancer (2023) Vol. 27, Iss. 1, pp. 49-71
Open Access | Times Cited: 15
The role of non-coding RNAs in the diagnosis of different stages (HCC, CHB, OBI) of hepatitis B infection
Omid Gholizadeh, Sama Akbarzadeh, Masood Moein, et al.
Microbial Pathogenesis (2023) Vol. 176, pp. 105995-105995
Closed Access | Times Cited: 13
The current status and future of PD-L1 in liver cancer
Liyuan Hao, Shenghao Li, Jiali Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma
Fanhong Zeng, Yue Zhang, Xu Han, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2775-2789
Open Access | Times Cited: 30
lncRNA MIAT targets miR‐411‐5p/STAT3/PD‐L1 axis mediating hepatocellular carcinoma immune response
Xiaoxia Zhang, Banglun Pan, Jiacheng Qiu, et al.
International Journal of Experimental Pathology (2022) Vol. 103, Iss. 3, pp. 102-111
Open Access | Times Cited: 21
Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
Juan L López-Cánovas, Natalia Hermán‐Sánchez, María Trinidad Moreno-Montilla, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 19
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5178-5178
Open Access | Times Cited: 12
The Genetic Changes of Hepatoblastoma
Huitong Chen, Qian Guan, Huiqin Guo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top